Navigation Links
Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
Date:7/31/2012

SONOMA, Calif., July 31, 2012 /PRNewswire/ -- When deciding how to treat common ailments such as arthritis, migraines, eczema, psoriasis, acne, or toe nail fungus, millions of Americans are looking for non-toxic alternatives to traditional pharmaceuticals.  Instead of relying on chemical-filled or steroid-laced drugs that can often trigger harmful side effects, many are now choosing organic medicines to treat and heal their health conditions.

Forces of Nature® offers more than 50 FDA-registered medicines that are chemical-free, fast-acting, and deliver guaranteed healing results without adverse reactions.  Made in the United States in an FDA-Registered Manufacturing Facility, they contain only natural ingredients and medicines that have been certified 100% organic by the US Department of Agriculture.

"Before now, people didn't have many treatment options that were chemical-free and affordable," said Dr. Peter Klapper, a PhD Biologist and the Founder of Forces of Nature®. "We've seen a dramatic surge in consumer interest. In the last 12 months our website has received over one million visits."

Klapper and his team of doctors and scientists invested 12 years into research and development to test and perfect the powerful plant-based medicines, while sourcing over 200 of the purest, most potent organic ingredients from around the world.

Forces of Nature® medicines are unique in many ways:

  • Every Forces of Nature® product is guaranteed to work and is backed by a one-year money back guarantee.
  • They're the only remedies that combine homeopathic medicines with therapeutic plant extracts to treat specific ailments. This one-two combination delivers powerful and effective results.
  • They're the on
    '/>"/>

SOURCE Forces of Nature
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans
2. NABP Applies for New .PHARMACY Generic Top-Level Domain to Provide a Secure Destination for Consumers
3. Worlds Only USDA Certified Organic and FDA Registered Homeopathic Medicines Guaranteed to Work
4. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
5. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
6. New Program Has Doctors, Patients Learn Together As Traditional Relationship Changes Forever
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... VERNE, Calif. , Oct. 22, 2014 /PRNewswire/ ... readiness products, has developed APLS ® Body ... that minimizes the spread of bacteria and virus ... APLS Body Guard Bio features a rugged, ... finished edges that create a leak-proof inner chamber ...
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on ... reported positive top-line clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes. The ... States under a U.S. Food and ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... Dec. 12, 2011 /PRNewswire-iReach/ -- Reagent ... a common compliance concern driving Quality Control departments ... VerGo Pharma Research proves to be an innovative ... their business practices this month.  Harness ...
... Phase III clinical trial data presented today contribute ... Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in ... have deeper levels of response compared to those ... The findings from the ENEST (Evaluating Nilotinib Efficacy ...
Cached Medicine Technology:VerGo Integrates New Solution for Tracking Compliance Dates 2Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 2Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 3Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 4Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 5Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 6Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 7Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 8Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 9Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 10Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 11Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 12Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 13Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 14Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 15Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 16
(Date:10/22/2014)... Arbor, MI (PRWEB) October 22, 2014 ... of Schools of Allied Health Professions (ASAHP) Conference on ... Founder and CEO will participate in a panel discussion ... and Practice. , Isabel Healthcare provides a diagnostic decision ... in improving the diagnosis skills of students and clinical ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... Beth Israel Deaconess Medical Center (BIDMC) have received funding ... their 2009 Creativity Awards program, which supports innovative ideas ... , The one-year awards were made to 10 ... the only institution in New England to be funded ...
... 14 All it takes is "a big chunk of change" ... employee spearheaded the effort to raise more than $1,000 ... that supports families of children with congenital heart defects or heart ... checking account, we can start to do things that we,ve wanted ...
... April 14 Intrinsic Therapeutics, Inc. announced today that ... anular prosthesis for use in reconstructing soft tissues of ... to distribute the Barricaid throughout the European Union and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090414/NE98588LOGO ...
... Major Parkinson,s Organization to Launch Web Site Exclusively ... N.Y., April 14 The American Parkinson Disease ... a re-designed Web site, www.youngparkinsons.org , created ... (PD), their family members, friends, and healthcare providers. ...
... patients got temporary reprieve from daily injections , , ... of stem cell transplantation using the patient,s own cells ... of 23 patients newly diagnosed with type 1 diabetes ... patient even managed to go four years without needing ...
... STEWARTVILLE, Minn., April 14 Rochester Medical Corporation (Nasdaq: ... close on Thursday, April 30, 2009. The Company will ... report. The call will begin at 4:00 p.m. central ... Thomson/CCBN and can be accessed at Rochester Medical,s website at ...
Cached Medicine News:Health News:BIDMC scientists receive creativity awards from Prostate Cancer Foundation 2Health News:TAN's Efforts Produce 'Chunk of Change' for Children With Heart Defects 2Health News:Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis 2Health News:New Young Onset Parkinson's Disease Web Site Goes Live 2Health News:New Young Onset Parkinson's Disease Web Site Goes Live 3Health News:Stem Cells Buy Freedom From Insulin for Type 1 Diabetics 2Health News:Stem Cells Buy Freedom From Insulin for Type 1 Diabetics 3Health News:Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009 2
Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
... technology that precisely focuses a column ... surgical site. Patented prism based technology ... illumination, shadow control, heat management and ... PrismAlix Series is available in a ...
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
Medicine Products: